EUVIMEDEUVIMED entdecken
Crossref

Abstract TH193: Uncontrolled Hypertension - Patient Profiles in Japan: The EnligHTN-Japan Study

Kazuomi Kario, Tadateru Hamada, Tom Norris, Esteban Coto, Kossi Dovene Abalo, Masayoshi Takeda, Takuya Kishi

Hypertension · 2026-10 · 83 (Suppl_1)

DOI: 10.1161/hyp.83.suppl_1.th193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Kazuomi Kario und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Understanding uncontrolled hypertension (uHTN) and the characteristics of patients with uHTN is essential to improve patient care. Hypothesis: We hypothesized that uHTN is common among patients in Japan receiving ≥2 antihypertensive drug classes and is accompanied by frequent cardiorenal and metabolic comorbidities.

Methods

EnligHTN-Japan is an ongoing observational study using medical claims data to assess the burden of uHTN. Patients in the DeSC database with a diagnosis of hypertension (HTN) treated with ≥2 antihypertensive drugs between January 1, 2018, and June 30, 2024, were included. Patients were considered to have uHTN if their first blood pressure (BP) measurement while treated with ≥2 antihypertensive drugs for ≥30 days (index date) was ≥130/80 mmHg (i.e., systolic BP [SBP] ≥130 mmHg or diastolic BP [DBP] ≥80 mmHg). Patient characteristics at index were summarized.

Results

Of patients treated with ≥2 antihypertensive drugs (n=59,922), 63.1% (n=37,794) were considered to have uHTN. Mean (standard deviation) age was 57.6 (9.9) and 71.5% were male ( Table 1 ). The median SBP was 136.0 mmHg (25 th , 75 th centile: 130.0, 145.0), with 37.8% of patients having an SBP ≥140 mmHg. The most common comorbidities were dyslipidemia (35.5%), chronic kidney disease (33.0%), liver disease (23.1%), and heart failure (13.4%); 51.9% of patients had obesity (defined by ICD-10 code or body mass index ≥25 kg/m 2 ). In the study population, 86.1% of patients were taking two antihypertensive medications, with 12.2% and 1.7% taking three and four or more, respectively.

Conclusions

In this large database-derived cohort in Japan, nearly two thirds of patients receiving ≥2 antihypertensive drug classes had BP ≥130/80 mmHg. The predominance of two-class therapy, together with frequent renal and metabolic comorbidities, suggests opportunities for treatment optimization and targeted management of cardiometabolic risk.

Zitieren

APA

Kario, K., Hamada, T., Norris, T., Coto, E., Abalo, K. D., Takeda, M., & Kishi, T. (2026). Abstract TH193: Uncontrolled Hypertension - Patient Profiles in Japan: The EnligHTN-Japan Study. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.th193

Vancouver

Kario K, Hamada T, Norris T, Coto E, Abalo KD, Takeda M, et al. Abstract TH193: Uncontrolled Hypertension - Patient Profiles in Japan: The EnligHTN-Japan Study. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.th193

BibTeX
@article{Kario2026,
  author = {Kario, Kazuomi and Hamada, Tadateru and Norris, Tom and Coto, Esteban and Abalo, Kossi Dovene and Takeda, Masayoshi and Kishi, Takuya},
  title = {Abstract TH193: Uncontrolled Hypertension - Patient Profiles in Japan: The EnligHTN-Japan Study},
  journal = {Hypertension},
  year = {2026},
  volume = {83},
  number = {Suppl_1},
  doi = {10.1161/hyp.83.suppl_1.th193}
}
Kostenlos starten →